Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
I am a long-term survivor of Multiple Myeloma, an incurable blood cancer. From the tine of my diagnosis in early 1994 until my oncologist told me “there is nothing more we can do for you, “
Continue reading“…deaths from cardiovascular disease among cancer patients…has shown that more than one in ten cancer patients do not die from their cancer but from heart and blood vessel problems instead…” The
Continue readingI am a long-term multiple myeloma (MM) survivor. I live with several long-term treatment-related side effects. As such I work hard to maintain my health. Nutrition is a crucial part of fitness according
Continue readingMy name is David Emerson. I am a long-term survivor of an incurable blood cancer called multiple myeloma. I can tell you without a doubt that the lifestyle changes outlined below are central to how I have
Continue readingSteroid-induced shoulder avascular or osteonecrosis is one of a string of long-term and late stage side effects that occurred during the years after my conventional therapies following my multiple myeloma
Continue readingAccording to research 95% of all MM is diagnosed at stage 2 or 3, that is to say advanced. MM is difficult to see coming. Therefore stabilizing MM patients is oncology’s priority. The standard-of-care
Continue reading“Better sleep is just one benefit of meditation…meditation can also: relieve stress, reduce anxiety, improve cognition, improve your pain response, control high blood pressure, improve
Continue reading“These findings provide further insights regarding the impact of omega-3 PUFAs administration on left ventricle performance indices, systemic inflammation and fibrosis biomarkers in patients with
Continue reading“HSCT patients who have survived for at least 5 years post-transplantation are at a fourfold to ninefold increased risk of late mortality for as long as 30 years from HSCT, producing an estimated
Continue reading“CIPN isn’t uncommon. Of people with cancer who are treated with chemotherapy, about 30 to 40 percent develop CIPN. It’s one of the reasons that some stop cancer treatment early…” I
Continue reading“It seems that the studies of Sarfaraz and colleagues lead to the direction that cannabinoids should be considered as agents for the management of prostate cancer..” I was aware of a non traditional
Continue reading“Peripheral neuropathy can be part of a paraneoplastic syndrome accompanying the disease but more commonly is a consequence of treatment with neurotoxic therapies, and produces sensory, motor, autonomic
Continue reading